These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18631749)

  • 1. Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Handb Clin Neurol; 2008; 89():245-60. PubMed ID: 18631749
    [No Abstract]   [Full Text] [Related]  

  • 2. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.
    Hamley IW
    Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemistry of alzheimer's disease].
    Hasegawa N; Ihara Y
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):119-23. PubMed ID: 1673700
    [No Abstract]   [Full Text] [Related]  

  • 6. Membrane trafficking pathways in Alzheimer's disease.
    Rajendran L; Annaert W
    Traffic; 2012 Jun; 13(6):759-70. PubMed ID: 22269004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of amyloid beta-protein in Alzheimer's disease.
    Liddell M; Owen MJ
    Lancet; 1992 Oct; 340(8823):851. PubMed ID: 1357270
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 9. APP processing and the APP-KPI domain involvement in the amyloid cascade.
    Menéndez-González M; Pérez-Pinera P; Martínez-Rivera M; Calatayud MT; Blázquez Menes B
    Neurodegener Dis; 2005; 2(6):277-83. PubMed ID: 16909010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular cytogenetic study and chromosome abnormalities in Alzheimer's disease. Protease-inhibitory peptides and amyloid beta protein in Alzheimer's disease].
    Ito H; Kitaguchi N
    Nihon Rinsho; 1988 Jul; 46(7):1514-20. PubMed ID: 3065525
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemistry study on brain pathology in Alzheimer's disease. Biochemical approach to the etiological mechanism].
    Nukina N
    Nihon Rinsho; 1988 Jul; 46(7):1475-83. PubMed ID: 3065524
    [No Abstract]   [Full Text] [Related]  

  • 12. MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
    Schonrock N; Matamales M; Ittner LM; Götz J
    Exp Neurol; 2012 Jun; 235(2):447-54. PubMed ID: 22119426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of Alzheimer's disease.
    Müller-Hill B; Beyreuther K
    Annu Rev Biochem; 1989; 58():287-307. PubMed ID: 2673012
    [No Abstract]   [Full Text] [Related]  

  • 14. The 7th Leonard Berg Symposium, Part 3.
    Strobel G
    J Alzheimers Dis; 2010; 21(1):315-21. PubMed ID: 20657051
    [No Abstract]   [Full Text] [Related]  

  • 15. β-adrenergic receptor, amyloid β-peptide, and Alzheimer's disease.
    Wang D; Xiang YK
    Curr Top Membr; 2011; 67():205-28. PubMed ID: 21771492
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of the amyloid β and/or of β-amyloid precursor protein of the fetus with trisomy 21 to the maternal blood stream and its possible contribution to the pathogenesis of the maternal Alzheimer's Disease.
    Mohamad López H
    Med Hypotheses; 2011 Dec; 77(6):1058-61. PubMed ID: 21944886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathology of Alzheimer's disease.
    Harrington CR
    Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
    Hirai S; Okamoto K
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.